EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Moderate increase of MET in hepatocytes protects against cholestatic liver injury by promoting an effective antioxidant response

Carlos González-Corralejo, Juan García-Sáez, María Figueroa-Fuentes, Annalisa Addante, Cesáreo Roncero, Nerea Lazcanoiturburu, Beatriz Pacheco, Julián Sanz, Cristina Gato, Eva Fernández-Calderón, María de la O López, Águeda González-Rodríguez und 5 weitere

The FEBS Journal · 2025

DOI: 10.1111/febs.70315 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FEBS Journal, 2025. Verfasst von Carlos González-Corralejo und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid (UCM), Spain. Hauptthemen laut MEDLINE: Hepatocytes, Proto-Oncogene Proteins c-met, Antioxidants, Cholestasis. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Science, Innovation and Universities, Spanish Agency of Research, and co-funded by European Regional Development Fund (ERDF), CIBEREHD, Instituto de Salud Carlos III, Universidad Complutense de Madrid (UCM) and Banco Santander.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocyte growth factor (HGF)/hepatocyte growth factor receptor (MET) signaling plays a critical role during liver regeneration upon acute and chronic damage, and is therefore an interesting target for therapeutic intervention. Nevertheless, the molecular mechanisms underlying the pro‐regenerative effects of HGF/MET signaling are not fully elucidated, particularly during cholestatic injury. Our aim was to analyze the impact of moderately enhanced MET on the hepatic response to cholestatic injury, and uncover the mechanisms behind it. For that, Alb‐R26 Met mice expressing a wild‐type Met transgene in albumin‐positive liver cells were fed with a 3,5‐diethoxycarbonyl‐1,4‐dihydrocollidine (DDC)‐supplemented diet, used as a model simulating human primary sclerosing cholangitis. Results indicate that increased MET expression diminished liver damage in DDC‐fed mice, evidenced by lower serum levels of bilirubin and alkaline phosphatase, and decreased cell apoptosis. However, decreased ductular expansion was observed, which together with enhanced hepatocyte proliferation suggests that hepatocytes act as the main cellular defense. Both in vivo and in vitro studies using Alb‐R26 Met liver‐derived hepatocytes under cholestasis‐simulated in vitro conditions demonstrated an enhanced upregulation of nuclear factor erythroid 2‐related factor 2 (NRF2; encoded by the Nfe2l2 gene), parallel to an upregulation of glutathione biosynthesis enzymes, increased levels of glutathione, and decreased reactive oxygen species, along with decreased activation of transforming growth factor beta (TGF‐β)‐induced signaling. Consistently, MET transgenic hepatocytes were protected against TGF‐β‐induced oxidative stress and apoptosis in vitro . In conclusion, our work evidences that moderate upregulation of wild‐type MET in hepatocytes is sufficient to promote a strong antioxidant response in the liver that efficiently protects against chronic cholestasis, thus allowing optimal liver regeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepatocytesProto-Oncogene Proteins c-metAntioxidantsCholestasisAnimalsMiceNF-E2-Related Factor 2HumansMice, TransgenicLiverOxidative StressApoptosisSignal TransductionLiver RegenerationMaleCell ProliferationDicarbethoxydihydrocollidineHepatocyte Growth FactorMice, Inbred C57BLDisease Models, AnimalPyridines

Stichwörter der Autor:innen

Metcholestasisglutathioneliver regenerationoxidative stress

Substanzen

Proto-Oncogene Proteins c-metAntioxidants3,5-diethoxycarbonyl-1,4-dihydrocollidineNF-E2-Related Factor 2DicarbethoxydihydrocollidineHepatocyte Growth FactorPyridines

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid (UCM), Spain.
  • Health Research Institute of the "Hospital Clínico San Carlos" (IdISSC), Madrid, Spain.
  • Anatomical Pathology Service of the "Clínica Universidad de Navarra", Madrid, Spain.
  • Department of Psychiatry, Legal Medicine and Anatomical Pathology, Faculty of Medicine, UCM, Madrid, Spain.
  • Sols Morreale Biomedical Research Institute, Spanish National Research Council and Autonomous University of Madrid (IIBM, CSIC-UAM), Spain.
  • Biomedical Research Networking Center in Diabetes and Associated Diseases (CIBERDEM-ISCIII), Madrid, Spain.

ORCID-Profile: Blanca Herrera, Aránzazu Sánchez

Förderung

  • Ministry of Science, Innovation and Universities, Spanish Agency of Research, and co-funded by European Regional Development Fund (ERDF)
  • CIBEREHD, Instituto de Salud Carlos III
  • Universidad Complutense de Madrid (UCM) and Banco Santander
  • NextGenerationEU
  • FP7-People: Marie Curie Actions
  • Comunidad de Madrid and co-funded by European Social Fund: Youth Employment Initiative (YEI)
  • European Regional Development Fund

Zitieren

APA

González-Corralejo, C., García-Sáez, J., Figueroa-Fuentes, M., Addante, A., Roncero, C., Lazcanoiturburu, N., Pacheco, B., Sanz, J., Gato, C., Fernández-Calderón, E., López, M. O., González-Rodríguez, Á., Porras, A., Maina, F., Fabregat, I., Herrera, B., & Sánchez, A. (2025). Moderate increase of MET in hepatocytes protects against cholestatic liver injury by promoting an effective antioxidant response. The FEBS Journal. https://doi.org/10.1111/febs.70315

Vancouver

González-Corralejo C, García-Sáez J, Figueroa-Fuentes M, Addante A, Roncero C, Lazcanoiturburu N, et al. Moderate increase of MET in hepatocytes protects against cholestatic liver injury by promoting an effective antioxidant response. The FEBS Journal. 2025. doi:10.1111/febs.70315

BibTeX
@article{GonzlezCorralejo2025,
  author = {González-Corralejo, Carlos and García-Sáez, Juan and Figueroa-Fuentes, María and Addante, Annalisa and Roncero, Cesáreo and Lazcanoiturburu, Nerea and Pacheco, Beatriz and Sanz, Julián and Gato, Cristina and Fernández-Calderón, Eva and López, María de la O and González-Rodríguez, Águeda and Porras, Almudena and Maina, Flavio and Fabregat, Isabel and Herrera, Blanca and Sánchez, Aránzazu},
  title = {Moderate increase of MET in hepatocytes protects against cholestatic liver injury by promoting an effective antioxidant response},
  journal = {The FEBS Journal},
  year = {2025},
  doi = {10.1111/febs.70315}
}
Kostenlos starten →